Display search results for ** instead (1636 products)

Showing 1-10 of 1636

13 Sep 2021  |  North America

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of ph...

USD 4,950.00
03 Sep 2021  |  North America

Global Renal Care Management Growth Opportunities

Value-based Renal Care to be a Key Growth Area

The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

USD 4,950.00
31 Aug 2021  |  Global

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management

Technology Developments Driving Transformational Growth in Treatment Modalities for Obstructive Lung Diseases

Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

USD 4,950.00
27 Aug 2021  |  North America

US and EU Upstream Bioprocessing Growth Opportunities

Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

USD 4,950.00
03 Aug 2021  |  North America

Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines

During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...

USD 4,950.00
12 Aug 2021  |  North America

Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

USD 4,950.00
16 Aug 2021  |  North America

Global Drug Discovery and Early Development Outsourcing Growth Opportunities

Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

USD 4,950.00
05 Aug 2021  |  Global

Global Wound Care Solutions and New-age Technology Growth Opportunities

Growth Strategies Driven by Increasingly Advanced and Digital Solutions

The entire healthcare industry is undergoing a transformation in the wake of the COVID-19 pandemic, and the global wound care industry is no exception. As concerns about aged patients contracting COVID-19 increased, care delivery began a gradual shift toward a home setting. As a result, participants in the wound care industry are investing heavily ...

USD 4,950.00
27 Jul 2021  |  Global

Wearable Artificial Organ Growth Opportunities

Technological Innovations Enabling Remote Monitoring and Home Care for Organ Dysfunction

Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outc...

USD 4,950.00
23 Jul 2021  |  North America

US Digital Therapeutics Growth Opportunities

Transformational Growth in New Business Models After COVID-19

Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...

USD 4,950.00

Showing 1-10 of 1636